Grant Amount: Variable (anticipated up to $25,000 direct costs per project per participating institution)
Deadline: Letter of intent by February 14, 2022; Application by March 14, 2022
Link to complete RFA
Additional Information -
The Clinical and Translational Science Awards (CTSA) of the University of New Mexico Health Sciences Center (UNM HSC), University of Kansas Medical Center (KUMC), University of Kentucky, University of Arkansas for Medical Sciences (UAMS), University of Iowa and the University of Utah Health are soliciting applications from all faculty members—senior as well as junior investigators—for pilot projects that will exemplify the CTSA mission of developing clinical and translational research, to promote and support the “bench to bedside to community and practice and back” goal of the National Institutes of Health, National Center for Advancing Translational Science (NCATS). The purpose of this RFA is to promote inter‐institutional collaboration across the CTSA consortium by funding innovative, translational research projects that involve three or more of these six CTSA institutions.
In accordance with the National Institutes of Health (NIH) strategic plan and its commitment to increasing representation in research, funding priority for this RFA will be given to research which addresses one of the following:
- Climate Change and Environmental Health
- Health Equity for Underrepresented Populations
- For example, pediatric populations, older adults, people with disabilities and/or rare disorders, underrepresented racial/ethnic and/or sexual and gender minorities, rural populations or populations with low socio-economic status. Click here for more details.
- Rural Health
- Maternal Health
Involvement of these groups is not a requirement for funding, but projects which address health concerns that disproportionately affect one or more of these groups, or projects that seek to apply or test general treatments or research approaches to one of more of these groups are preferred.
The translational science spectrum represents each stage of research along the path from the biological basis of health and disease to interventions that improve the health of individuals and the public. The spectrum is not linear or unidirectional; each stage builds upon and informs the others. At all stages of the spectrum, NCATS develops new approaches, demonstrates their usefulness and disseminates the findings. Patient and/or community involvement is a critical feature of all stages in translation. Purely non-human animal research does not qualify for funding under this program.
The research activities at each participating site will be funded by that institution’s CTSA. Because each institution participating in this program decides how much funding will be devoted to the program, the amount of funding available will vary depending on the institutions of the investigators involved in a proposal. It is anticipated that funds up to $25,000 direct costs per project per participating institution may be available for these collaborative projects.
Please note: All funds not spent by the end date of the CTSA Inter‐Institutional Pilot Project Award will be returned to the participating institution and NIH. Extensions are not allowed.